- NJBS donation centers are located in Scotch Plains, NJ, and operate as part of the larger NYBC network.
- NYBC serves the tri-state area, and updates to FDA guidance affect eligibility for donations.
New York Blood Center Appoints CEO and Secures FDA Approval for HemaCord
What happened
The Board of Trustees of New York Blood Center Enterprises appointed Meghan Delaney as President and Chief Executive Officer. She is set to assume the role on January 4, 2027. The organization also secured FDA approval for HemaCord, which is noted as the first FDA-licensed hematopoietic progenitor cell therapy product.
From prnewswire.com
Why it matters
The FDA approval of HemaCord expands the capabilities of the New York Blood Center as a life sciences enterprise. The appointment of Meghan Delaney as CEO signals a leadership transition for the organization.
New York Blood Center serves the tri-state area, and updates to FDA guidance affect eligibility for donations.
From prnewswire.com
Who's involved
- New York Blood CenterOrganization that appointed the new CEO and received FDA approval for HemaCord
- Meghan DelaneyAppointed President and Chief Executive Officer of the New York Blood Center
- FDARegulatory agency that granted approval for the HemaCord product
Who could feel it
Possible knock-on effectsThese are possibilities Brind reasoned out, not predictions, and not advice. Most are not stated in any report.
- New York Blood CenterSpeculative
New York Blood Center might see increased revenue and market standing due to the FDA approval of HemaCord.
Keep exploring
The entities involved
-
New York Blood Center
organization
- FDA